GeneNews (GEN) Trading Down 13.3%

GeneNews Ltd (TSE:GEN) was down 13.3% during mid-day trading on Thursday . The company traded as low as C$0.12 and last traded at C$0.13. Approximately 1,032,049 shares were traded during trading, a decline of 38% from the average daily volume of 1,659,144 shares. The stock had previously closed at C$0.15.

The stock has a market capitalization of $22.10 million and a PE ratio of -4.14.

TRADEMARK VIOLATION NOTICE: This news story was first posted by Dakota Financial News and is owned by of Dakota Financial News. If you are accessing this news story on another website, it was stolen and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this news story can be read at https://dakotafinancialnews.com/2019/05/18/genenews-gen-trading-down-13-3.html.

About GeneNews (TSE:GEN)

GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.

Further Reading: Gap Up Stocks

Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.